Topics

We’re at #JPM20 and #BiotechShowcase, where Chris Sheldon (VP, Global Head of Business Development & Licensing), participated in a panel on how new technologies and collaboration are reshaping oncology. Learn more about our partnership opportunities: h

11:56 EST 14 Jan 2020 | AztraZeneca

We’re at and , where Chris Sheldon (VP, Global Head of Business Development & Licensing), participated in a panel on how new technologies and collaboration are reshaping oncology. Learn more about our partnership opportunities: http://bit.ly/2ZZw6ka 

Original Article: We’re at #JPM20 and #BiotechShowcase, where Chris Sheldon (VP, Global Head of Business Development & Licensing), participated in a panel on how new technologies and collaboration are reshaping oncology. Learn more about our partnership opportunities: h

NEXT ARTICLE

More From BioPortfolio on "We’re at #JPM20 and #BiotechShowcase, where Chris Sheldon (VP, Global Head of Business Development & Licensing), participated in a panel on how new technologies and collaboration are reshaping oncology. Learn more about our partnership opportunities: h"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...